New findings suggest reproductive endocrine disorders may stem more from rhythm disruptions than mere hormone quantity deficits, opening the door for rhythm-based diagnostics to catch subclinical dysfunction earlier and guide personalized fertility interventions.

Rhythm-based analyses, highlighted by Dr. Tinatin Kutchukhidze, outperformed conventional hormone testing in identifying subclinical reproductive dysfunction, signaling a shift toward predictive rhythm-based reproductive medicine.

AI-driven rhythm analyses surpassed traditional testing in detecting subclinical dysfunction, implying that timing, coordination, and rhythmic hormone patterns are central to reproductive health rather than absolute hormone levels.

Researchers plan to validate the Endocrine Rhythm Integrity (ERI) and the wearable patch in larger, more diverse populations to assess predictive value for fertility outcomes and potential clinical adoption.

If proven effective, the technology could become a clinically actionable tool for measuring endocrine-rhythm health and may be applied in transgender healthcare to monitor real-time hormonal dynamics during therapy.

The research was presented at the 28th European Congress of Endocrinology in Prague, underscoring a move toward chronodiagnostics and real-time hormone monitoring as a new frontier in fertility care and endocrine health.

A new AI-enabled wearable skin sensor patch can continuously monitor reproductive hormone fluctuations, not just single hormone levels, to help detect infertility earlier and guide conception efforts.

The patch tracks rhythmic hormone patterns over time, revealing hidden dysfunction linked to unexplained infertility in both men and women.

This AI-powered wearable enables real-time monitoring of reproductive hormone rhythms in both sexes, advancing beyond traditional static hormone tests.

Future plans include validating AI tools in larger, ethnically diverse populations and expanding rhythm-based diagnostics to other endocrine areas, including transgender hormone therapy, aiming for rhythm-informed standards in personalized endocrinology and reproductive medicine.

Researchers aim to broaden validation across diverse populations to test predictive power across reproductive conditions and move toward rhythm-based predictive fertility care and personalized interventions, with potential transgender healthcare benefits.

Researchers introduced ERI, an AI-driven metric that analyzes hormone patterns during the luteal phase alongside basal body temperature, heart rate, and sleep to assess fertility potential in 312 young women, finding lower ERI scores in unexplained infertility and higher implantation failure rates.